Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study-Reference-Cited by-同舟云学术

Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study

Published:2013-06 Issue:4 Volume:24 Page:324-332
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Gussoni Gualberto,Di Pasquale Giuseppe,Vescovo Giorgio,Gulizia Michele,Mathieu Giovanni,Scherillo Marino,Panuccio Domenico,Lucci Donata,Nozzoli Carlo,Fabbri Gianna,Colombo Fabrizio,Riva Letizia,Baldo Concetta I.,Maggioni Aldo P.,Mazzone Antonino

Publisher

Elsevier BV

Subject

Internal Medicine

Reference38 articles.

1. Risk for systemic embolization of atrial fibrillation without mitral stenosis;Cabin;Am J Cardiol,1990

2. Antithrombotic therapy for atrial fibrillation. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;You;Chest,2012

3. Guidelines for the management of atrial fibrillation;The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Eur Heart J,2010

4. Stroke severity in atrial fibrillation. The Framingham Study;Lin;Stroke,1996

5. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation;Gage;JAMA,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials;Neuroscience & Biobehavioral Reviews;2019-01

2. Italian intersociety consensus on DOAC use in internal medicine;Internal and Emergency Medicine;2017-02-13

3. How safe are non-vitamin K antagonist oral anticoagulants in atrial fibrillation?;European Heart Journal Supplements;2016-12-22

4. Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention;Medical Care;2016-10

5. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life;European Journal of Internal Medicine;2016-09